Biomednewsbreaks Renovorx Inc. (NASDAQ: RNXT) Announces $12.1M Underwritten Public Offering
RenovoRx (NASDAQ: RNXT) , a life sciences company developing novel targeted oncology therapies and commercializing RenovoCath(R), a novel, FDA-cleare ...
RenovoRx Announces $10.9 Million Public Offering of Common Stock
RenovoRx, Inc. (NASDAQ: RNXT) recently announced the execution of an underwriting agreement with Titan Partners Group LLC for a firm commitment underwritten public offering of its common stock. The ...
RenovoRx Highlights Promising Pre-Clinical Data Abstract: TAMP™ Therapy Platform Offers Potential to Improve Localized and Targeted Drug Delivery
RenovoRx, Inc. ("RenovoRx" or the "Company") (Nasdaq: RNXT), a life sciences company developing novel targeted oncology therapies and commercializing RenovoCath, an innovative, FDA-cleared device, ...
Weather Underground3d
Renovo, PA Weather Conditions
Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.
Weather Underground2d
Renovo, PA 10-Day Weather Forecast
Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.